Advanced search

Iain James Mackay occupies the position of Chief Financial Officer & Executive Director at GlaxoSmithKline Plc and Director & Finance Director at HSBC Holdings PLC (Hong Kong). He is also Court Member at the University of Aberdeen and Member of The Institute of Chartered Accountants of Scotland and on the board of 5 other companies.
He previously occupied the position of Executive Director & Group Finance Director at HSBC Holdings Plc Chief Financial Officer of The HongKong & Shanghai Banking Corp. Ltd. Chief Financial Officer at HSBC Asia Pacific Holdings (UK) Ltd. CFO & Senior Executive Vice President at HSBC Finance Corp. and Chief Financial Officer & Senior EVP at HSBC North America Holdings, Inc. (which are all subsidiaries of HSBC Holdings Plc), Finance Director-Europe, Africa & South East Asia at Dowell Schlumberger, Chief Financial Officer & Vice President for Global Life Sciences Solutions Manufacturing UK Ltd. and Chief Financial Officer & Vice President at GE Consumer Finance, Inc.
Mr. Mackay received a graduate degree from the University of Aberdeen.

Iain Ruaraidh Mackay is currently a Director at Red Sixty One Ltd.
He previously worked as a Non-Executive Director at Pufferfish Ltd.

Michelle M.
MacKay is currently the Chief Executive Officer & Director at Cushman & Wakefield Plc, the Chief Executive Officer at Cushman & Wakefield, Inc., the Chief Executive Officer at Cushman & Wakefield Sweden AB, and the Co-President, Chief Operating Officer & Director at Cushman & Wakefield Debenham Tie Leung Ltd.
Previously, she served as an Independent Director at WCI Communities, Inc. from 2009 to 2017, an Executive Director-Commercial Real Estate at UBS Warburg, Inc. from 1998 to 2001, an Assistant VP-Real Estate & Fixed Income at The Hartford Financial Services Group, Inc. from 1991 to 1996, a Vice President at Chase Bank USA, NA from 1996 to 1998, and an Executive VP-Investments & Head-Capital Markets at iStar, Inc. from 2003 to 2017.
She also served as an Independent Trustee at Americold Realty Trust, Inc. from 2018 to 2021.
Ms. MacKay holds an undergraduate degree from the University of Connecticut and an MBA from the University of Hartford.

Martin W.
MacKay is the founder and currently holds the position of Chairman & Chief Executive Officer at Rallybio LLC, which was founded in 2018.
He is also the Executive Chairman at Rallybio Corp., founded in 2018.
In addition to his founding positions, Dr. MacKay currently serves as the Chief Executive Officer at Calyx Group Ltd.
(Ireland) and Rallybio Holdings LLC.
He is also a Director at Charles River Laboratories International, Inc., an Independent Director at Charles River Laboratories, Inc., and an Independent Director at Novo Nordisk A since 2018.
Dr. MacKay has held former positions as the Chief Executive Officer at Vecta Software Corp.
Ltd., Neverfail, Inc., and Neverfail Ltd.
He was also a Director at Encysive Pharmaceuticals, Inc. in 2008.
Additionally, he has served as the Operations Director at The Dun & Bradstreet Corp.
and Director-Business Development at NorthgateArinso, Inc. Dr. MacKay was an Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022.
He held the position of Senior Vice President-Worldwide Development at Pfizer Inc. from 1995 to 2009 and President-Research & Development at AstraZeneca PLC from 2010 to 2013.
From 2013 to 2017, he was the Global Head-Research & Development at Alexion Pharmaceuticals, Inc. Dr. MacKay has also held positions at VeriSign, Inc., BASF Performance Products Ltd.
(United Kingdom), New Leaf Venture Partners LLC, Pfizer (St. Louis), CRI Worldwide LLC, PeopleSoft USA, Inc., Accenture LLC, Ciba-Geigy Pharmaceuticals, and Beecham Pharmaceuticals (UK).
Dr. MacKay obtained a doctorate degree from The University of Edinburgh in 1984 and an undergraduate degree from Heriot-Watt University in 1979.

Alick Mackay is currently the Director of Strategy & Corporate Development at Brooks MacDonald Group Plc since 2017.
Prior to this, he worked as the Chief Operating Officer at NatWest Group Plc.
Mr. Mackay has an undergraduate degree from the University of Aberdeen, a graduate degree from The Open University, and an MBA from Columbia Business School.

Iain Rob Rayner occupies the position of Joint Chief Operating Officer at St. James's Place Plc. Mr. Rayner is also on the board of St. James’s Place Acquisition Services Ltd. and St. James's Place DFM Holdings Ltd.

Iain Wetherall occupies the position of Chief Investment Officer of Wizz Air Holdings Plc.

Iain Michael Brown holds the position of Senior VP, Chief Financial & Accounting Officer at Alkermes Plc. In his past career Mr. Brown occupied the position of Vice President-Finance for Alkermes, Inc. and Vice President-Finance at EMD Serono, Inc. He received an undergraduate degree from the University of Bradford.

Presently, Iain Boyd holds the position of Vice President-Operations Development at Snap-On, Inc. He previously occupied the position of Vice President-Human Resources of Snap-on Tools Co. LLC.

Iain Charles Andrew Cornish is a businessperson who has been at the head of 6 different companies. Presently, he is Chairman at Leeds Building Society. Mr. Cornish is also Treasurer & Trustee at Macmillan Cancer Support and on the board of 5 other companies. Mr. Cornish previously was Chairman for St. James's Place Plc, Chairman of Shawbrook Group Plc and Chairman of Shawbrook Bank Ltd. (a subsidiary of Shawbrook Group Plc), Chief Executive Officer of Yorkshire Building Society and Chairman at Building Societies Association. He received an undergraduate degree from The University of Southampton.

Presently, Iain Blacklaw holds the position of Chief Operating Officer of National Bank of Bahrain. In the past he occupied the position of Chief Operating Officer for Al Rajhi Bank. He received an undergraduate degree from the University of Aberdeen.

Currently, Iain George Williamson is Chief Executive Officer & Executive Director at Old Mutual Ltd. and Chief Executive Officer at Old Mutual Life Assurance Co. (South Africa) Ltd. (a subsidiary of Old Mutual Ltd.) and Chief Executive Officer of Old Mutual Life Assurance Co. Ltd. He is also on the board of Nedbank Group Ltd., Nedbank Ltd. and UAP Old Mutual Group Ltd. Mr. Williamson previously held the position of Finance Director of Old Mutual Emerging Markets Ltd.

Iain C. Conn is on the board of BT Group Plc and Oxford Flow Ltd. and Member of European Round Table of Industrialists. In the past Mr. Conn was Chief Executive Officer & Executive Director at Centrica Plc, Executive Director & CEO-Marketing & Refining at BP Plc and Chief Executive Officer for BP Petrochemicals Ltd. (a subsidiary of BP Plc) and Council Member at Imperial College London. He received an undergraduate degree from Imperial College London.

Dr. Iain D. Dukes is a Chief Executive Officer at Viriom, Inc., a President & Director at Kartos Therapeutics, Inc., an Independent Director at Ikena Oncology, Inc., a Venture Partner at OrbiMed Advisors Private Equity, a Chairman at Iovance Biotherapeutics, Inc., an Executive Chairman at Theseus Pharmaceuticals, Inc., a President at Telios Pharmaceuticals, Inc. and a President & Chief Executive Officer at Arrys Therapeutics, Inc. He is on the Board of Directors at Angiex, Inc., ENYO Pharma SA, Kartos Therapeutics, Inc., Ikena Oncology, Inc., NeRRe Therapeutics Holdings Ltd., NeRRe Therapeutics Ltd. and ReViral Ltd. Dr. Dukes was previously employed as a Member-Supervisory Board by Themis Bioscience GmbH, a SVP & Head-Business Development by Merck Research Laboratories Massachusetts LLC, a VP-External Research & Development by Amgen, Inc., a President & Chief Executive Officer by Essentialis, Inc., a VP-Scientific and Technology Licensing by GlaxoSmithKline, Inc., a Head-Exploratory Development by Glaxo Wellcome, Inc., a Principal by Glaxo, Inc., and a Senior VP-Business Development & Licensing by Merck & Co., Inc. He also served on the board at KaNDy Therapeutics Ltd. He received his undergraduate degree from the University of Bath, an undergraduate degree from the University of Oxford, a graduate degree from the University of Leeds and a doctorate degree from the University of Oxford.

Iain G. T. Ferguson is a businessperson who has been the head of 11 different companies and presently is Non-Executive Chairman at Genus Plc, Non-Executive Chairman at Crest Nicholson Holdings Plc, Non-Executive Chairman of Crest Nicholson Plc (a subsidiary of Crest Nicholson Holdings Plc) and Chairman at Hallmarq Veterinary Imaging Ltd. Mr. Ferguson is also Chancellor at Cranfield University and on the board of 5 other companies. In his past career Iain G. T. Ferguson occupied the position of Non-Executive Chairman at Stobart Group Ltd., Chief Executive Officer at Tate & Lyle Plc, Senior Vice President-Corporate Development at Unilever Plc, Non-Executive Chairman for Berendsen Ltd., Chief Executive Officer for Birds Eye Ltd., Member of PricewaterhouseCoopers LLP (United Kingdom), Member-Strategy Group at United Kingdom Department for Business, Innovation & Skills, Chairman of Wilton Park, President of The Institute of Grocery Distribution and President at The Food & Drink Federation. Mr. Ferguson received an undergraduate degree from the University of St. Andrews.

James Morrison MacKay is currently the Chairman of True Product ID Technology (Beijing) Ltd.
He was previously the Chairman of MacKay Life Sciences, Inc. and Sure Trace Security Corp.
In 2007, he was the Chairman of True Product ID, Inc. and in 2006, he was the Interim Chairman of True Product ID, Inc.

Mr. Adrian L.
Mackay is a Portfolio Manager & Fund Advisor at Freestyle Fund Services Co. LLC.
Prior to founding Freestyle Fund Services in September 2002, Mr. Mackay was employed as a Managing Director by ING Barings LLC and Furman Selz LLC and an Investment Banker by Kidder Peabody and Lehman Brothers Asset Management LLC.
He received his BSc in Electronic Engineering from The University of Southampton and his MBA from Tulane University.
He also completed the PADE at IESE Business School in Spain.

Geoff MacKay was the founder of Avrobio, Inc. (founded in 2015) where he held the title of President, Chief Executive Officer & Director until 2023.
He is also the founder of eGenesis, Inc. (founded in 2015) where he held the title of Chief Executive Officer & Director until 2017.
Currently, Mr. MacKay is the Chairman of Satellos Bioscience, Inc. since 2018 and a Director at RedactBio, Inc. His former positions include President & Chief Executive Officer at Organogenesis, Inc. from 2003 to 2014, Chief Executive Officer at Organogenesis, Inc., Chairman of Massachusetts Biotechnology Council, Chairman of Alliance for Regenerative Medicine, Chairman of Satellos Bioscience, Inc., Independent Director at RepliCel Life Sciences, Inc., Director at Centre For Commercialization of Regenerative Medicine, Independent Director at Talaris Therapeutics, Inc., Director at Gemstone Biotherapeutics LLC, and Vice President at Novartis AG.
Mr. MacKay also served as an Advisor at Atlas Venture Advisors, Inc. from 2015 to 2023.
He obtained his undergraduate degree from McGill University.

Michelle Mackay is currently the Director at The FSHD Society since 2010.
Prior to this, she worked as a Director at Food Bank of South Central Michigan, Inc.

Williams L.
MacKay worked as a Senior Vice President at Alaska Airlines, Inc.

Mr. Russell I.
MacKay is a Private Wealth Advisor & Portfolio Manager at CWB Wealth Partners Ltd.
As a Portfolio Manager, he draws on his years of experience and professional network to help our clients properly align their portfolio to their goals and objectives, and serve as a sounding board for broader wealth issues.
He became a founding partner in CWB Wealth Partners in 1999 because of his belief in the client-focused business model.
Mr. MacKay was employed as an Investment Advisor by BMO Nesbitt Burns, Inc. and a Principal by Shaw Communications, Inc. He received his undergraduate degree from the University of Lethbridge.

Andrew R.
MacKay formerly worked at IG Group Holdings plc, as Executive Director & Director-Corporate Strategy in 2012 and LIFFE Holdings Plc, as Manager-Market Investigations.
Mr. MacKay received his graduate degree from the University of St. Andrews.

Steven J.
Mackay was the founder who founded Selkirk Energy Partnership in 2002 and served as its President in 2005.
He worked as a Regional Geologist at Burlington Resources Canada Ltd.
from 1986 to 1995 and as a Vice President-Exploration at Insignia Energy Ltd.
Mr. Mackay earned an undergraduate degree from the University of Alberta in 1985.

Tristan Scott Mackay is currently the Director of Trading & Institutional Equity at National Bank Trust, Inc. He previously worked as the Managing Director-Institutional Trading at Casimir Capital Ltd.
from 2011 to 2013.
He also worked as a Trader at Wellington West Capital Markets, Inc. Mr. Mackay received his undergraduate degree from McGill University in 2005 and his MBA from Richard Ivey School of Business in 2016.

Mr. Murray A.
Mackay is an Executive Director at Investec Wealth & Investment Ltd.
He manages his own bank of private clients, trusts and pensions and is responsible for the Edinburgh office.
He is also the Regional Director for Scotland and Northern Ireland and sits on the company’s board.
He started his stockbroking career in 1987 at Alexanders Laing & Cruikshank.
In 1989, he joined Allied Provincial, which eventually became Gerrard and was ultimately acquired by Barclays Wealth.
He was a Director and Regional Centre Head for the firm’s Edinburgh Office before joining Williams De Broe (now Investec Wealth & Investment) in September 2008.
Mr. Mackay graduated from Edinburgh University with a Bachelor of Commerce Degree in 1984.
He is a Chartered Fellow of the Securities Institute.

Joscelyn MacKay is currently the Director of Data Products at Morningstar, Inc. (Research).
Prior to this, Joscelyn worked as a Research Assistant at Deutsche Bank Securities, Inc. from 2001 to 2004.
From 2006 to 2008, Joscelyn was an Associate at Banc of America Securities LLC.
In 2008, Joscelyn worked as an Investment Associate at Prudential Capital Group.
Joscelyn completed an undergraduate degree at Georgetown University in 2000 and obtained an MBA from The University of Chicago Booth School of Business in 2006.

Robert MacKay formerly worked at Abtech Holdings, Inc., as CFO, Secretary, Treasurer, Director & CAO from 2010 to 2011.

Sherrill M.
MacKay worked as a Senior Director of Manufacturing at Vericel Corp..
Ms. MacKay attended the University of Michigan for undergraduate and graduate degrees.

Lindsay Mackay worked as a Director of Marketing and Business Development at Jolt Health, Inc.

Mr. Ben Mackay is a Principal at Evolve Capital Ltd.
and Executive Officer at Mission Critical Electronics, Inc. He received his undergraduate degree from Colby College and an MBA from Babson College.

Hugh G.
D.
Mackay is the founder of Disko Exploration Ltd.
founded in 2006.
Mr. Mackay is also the founder of Avannaa Resources Ltd.
Mr. Mackay's former job was as the Chief Executive Officer & Director at Europa Oil & Gas (Holdings) Plc from 2011 to 2019.
Mr. Mackay's education history includes an undergraduate degree from The University of Edinburgh and a graduate degree from London Business School.

Miguel Rodríguez Mackay served as the Minister of Foreign Affairs for the Government of Perú in 2022.

Matthew Mackay is currently the Chief Financial Officer at Humble & Fume, Inc. Prior to this, he obtained an undergraduate degree from Brock University.

Coral Mackay currently works as a Director for K'omoks First Nation Forestry Corp.

Craig Ross MacKay is a member of the Australasian Institute of Mining & Metallurgy and the Australian Institute of Co. Directors.
He previously worked as the Managing Director & Non-Independent Director at Asara Resources Ltd.
from 2012 to 2022.

Mr. Gordon A.
Mackay is a Portfolio Manager at Janus Henderson Investors UK Ltd.
He has held this position since joining Henderson in 2016.
Mr. Mackay is also a Portfolio Manager on the International Opportunities strategy.
He has over 26 years of financial industry experience.
Mr. Mackay was a senior investment analyst at Speirs & Jeffrey Ltd covering a range of UK equity sectors.
From 2004 to 2014, he was a portfolio manager at Ignis Asset Management responsible for managing a range of Asian equity portfolios.
Prior to this, Mr. Mackay was with Abbey National Asset Managers for seven years, first as a trainee investment analyst covering North American equities before progressing to become an investment manager for that region.
He began his career at Clydesdale Bank plc as a bank officer in 1991.
He has a BA degree (Honors) in Economics and Finance from the University of Strathclyde.
He is an Associate Member of the Society of Investment Professionals (ASIP) and an Associate Member of the Chartered Banker Institute (ACBI).

Peter MacKay is an Independent Director at Cielo Waste Solutions Corp.
since 2021.
He completed his undergraduate degree from Acadia University in 1987 and his graduate degree from Dalhousie University in 1990.

Mr. Douglas S.
MacKay, CFA MBA, is a Founder, Chief Executive Officer & Chief Investment Officer at Broadleaf Partners LLC.
He is a registered investment advisor serving high net worth individuals, foundations and institutions.
He has been the Chief Investment Officer of the firm and Portfolio Manager of the Broadleaf Growth Equity Portfolio since its inception in August 2005.
Prior to launching Broadleaf, Mr. MacKay spent over fifteen years with one of Ohio’s largest, independently owned investment advisory firms.
While there, he developed and managed a research team consisting of six equity analysts and four portfolio managers and was also personally responsible for managing portfolios valued at more than $2.5 billion.
He also launched a successful family of no load mutual funds and was a key player in the firm’s overall growth, helping to attract more than $30 billion in assets under management from individuals and institutions around the country.
He is a past president of the Greater East Ohio Alzheimer’s Association and a current member of Miami University’s Farmer School of Business Advisory Board.
Mr. MacKay received his undergraduate degree from Miami University and an MBA from Case Western Reserve University.